The Chinese University of Hong Kong at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
The Chinese University of Hong Kong takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on multi-omic liquid biopsy supported by artificial intelligence, including real-world evidence from Asia on scale and affordability, alongside head and neck cancer. It also covers endpoints and new drug combinations for hepatocellular carcinoma, a form of liver cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
The Chinese University of Hong Kong Hong Kong, Hong Kong SAR China | |
Public research university in Hong Kong with a faculty of medicine based at Prince of Wales Hospital. | Satellite Fri Oct 23 09:45–11:15 Satellite Fri Oct 23 09:45–09:51 Welcome & Introduction Biomarkers & precision oncology Satellite Fri Oct 23 10:15–10:27 Chair Sun Oct 25 14:45–16:15 Rapid oral: Head and neck cancer Sarcoma, CNS, head & neck and rare cancers Abstract Sun Oct 25 15:27–15:39 Invited Discussant 1539RO, 1542RO and 1540RO Sarcoma, CNS, head & neck and rare cancers Talk Sun Oct 25 15:45–16:05 Hepatocellular carcinoma: Endpoint and new combinations Gastrointestinal cancers |
Instantly find 20 buyers from The Chinese University of Hong Kong
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction